Dr. Anthony J. Jaslowski
Claim this profileSaint Vincent Hospital Cancer Center Green Bay
Expert in Cancer
Studies Breast Cancer
23 reported clinical trials
42 drugs studied
Area of expertise
1Cancer
Global LeaderHER2 positive
Stage IV
ER positive
2Breast Cancer
HER2 positive
ER negative
PR negative
Affiliated Hospitals
Clinical Trials Anthony J. Jaslowski is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
HN-STAR
for Head and Neck Cancer
People who have been treated for head and neck cancer (HNC survivors) can experience serious consequences from their cancer and its treatment, ongoing risks of new cancers, and other unrelated illnesses. These concerns pose challenges to the provision of comprehensive care to HNC survivors. We created HN-STAR to facilitate and tailor the ongoing care of HNC survivors. Survivors use HN-STAR on a computer or tablet to answer questions about symptoms and health concerns before a routine visit with a cancer care provider. During the clinic visit, the provider uses HN-STAR to see evidence-based recommendations for managing each concern reported by the survivor. The provider and survivor discuss recommendations and select appropriate actions (e.g., testing, referrals, prescriptions, self-management). HN-STAR produces a survivorship care plan that includes all reported concerns and the actions selected in clinic. The survivorship care plan is given to the survivor and the primary care provider. Three months, six months, and nine months later, the survivor uses HN-STAR from home (or clinic) to report their concerns again, and a new survivorship care plan is created each time. Our trial randomizes 20-36 oncology practices from the National Community Oncology Research Program to use HN-STAR or provide usual care to 298-400 recent survivors of head and neck cancer. We hypothesize that survivors in the HN-STAR arm will have greater improvement in patient-centered outcomes (including cancer-related well-being, symptoms, and patient activation) over one year compared to survivors in the usual care arm, measured by surveys at baseline and one year later. We also hypothesize that survivors in the HN-STAR arm will be more likely to receive care that is aligned with evidence-based recommendations during the year of the study than survivors in the usual care arm. Our final aim investigates the implementation of HN-STAR in clinical practice, using interviews and surveys of survivors, providers, and other clinic staff to understand the feasibility, acceptability, appropriateness, and other aspects of providing survivorship care to head and neck cancer survivors.
Recruiting1 award N/A7 criteria
More about Anthony J. Jaslowski
Clinical Trial Related5 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Anthony J. Jaslowski has experience with
- Biospecimen Collection
- Questionnaire Administration
- Nivolumab
- Pembrolizumab
- Paclitaxel
- Trastuzumab Emtansine
Breakdown of trials Anthony J. Jaslowski has run
Cancer
Breast Cancer
Colorectal Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anthony J. Jaslowski specialize in?
Anthony J. Jaslowski focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Anthony J. Jaslowski currently recruiting for clinical trials?
Yes, Anthony J. Jaslowski is currently recruiting for 13 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Anthony J. Jaslowski has studied deeply?
Yes, Anthony J. Jaslowski has studied treatments such as Biospecimen Collection, Questionnaire Administration, Nivolumab.
What is the best way to schedule an appointment with Anthony J. Jaslowski?
Apply for one of the trials that Anthony J. Jaslowski is conducting.
What is the office address of Anthony J. Jaslowski?
The office of Anthony J. Jaslowski is located at: Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin 54301 United States. This is the address for their practice at the Saint Vincent Hospital Cancer Center Green Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.